CareTrust REIT (CTRE) Financials

$31.20 +0.50 (+1.63%)

As of 07/3/2025 03:30 PM Eastern

Annual Income Statements for CareTrust REIT

This table shows CareTrust REIT's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-8.14	10	29	26	58	46	81	72	-7.51	54	125
Consolidated Net Income / (Loss)	-8.14	10	29	26	58	46	81	72	-7.51	54	124
Net Income / (Loss) Continuing Operations	-8.14	10	29	26	58	46	81	72	-7.51	54	124
Total Pre-Tax Income	-8.14	10	29	26	58	46	81	72	-7.51	54	124
Total Operating Income	-8.14	33	52	47	84	73	105	107	25	80	82
Total Gross Profit	59	74	102	130	154	161	176	192	182	195	224
Total Revenue	59	74	105	133	157	163	178	192	188	199	229
Operating Revenue	59	74	105	133	157	163	178	192	188	199	229
Total Cost of Revenue	0.00	0.00	2.55	2.73	2.96	2.90	1.87	0.00	5.04	3.42	5.71
Operating Cost of Revenue	-	-	2.55	2.73	2.96	2.90	1.87	0.00	5.04	3.42	5.71
Total Operating Expenses	67	41	50	84	70	88	72	86	158	115	142
Selling, General & Admin Expense	11	7.66	9.30	11	13	15	16	27	20	22	29
Depreciation Expense	23	24	32	39	46	52	53	55	50	51	57
Other Operating Expenses / (Income)	33	9.08	8.17	33	12	4.12	2.84	3.57	8.18	6.17	14
Impairment Charge	-	0.00	0.00	0.89	0.00	17	0.00	0.00	79	36	42
Total Other Income / (Expense), net	0.00	-23	-23	-21	-26	-26	-24	-35	-32	-26	43
Interest Expense	-	24	23	24	28	28	24	35	30	41	31
Interest & Investment Income	-	0.97	0.00	3.54	-	-	-	-	8.63	19	67
Other Income / (Expense), net	0.00	0.00	-0.27	0.00	2.05	1.78	-0.04	-0.08	-11	-4.27	6.84
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	-	0.00	0.00	-0.01	-0.68
Basic Earnings per Share	($0.36)	$0.26	$0.52	$0.35	$0.73	$0.49	$0.85	$0.74	($0.08)	$0.50	$0.81
Weighted Average Basic Shares Outstanding	22.79M	37.38M	56.03M	72.65M	79.39M	93.09M	95.20M	96.02M	96.70M	105.96M	154.80M
Diluted Earnings per Share	($0.36)	$0.26	$0.52	$0.35	$0.72	$0.49	$0.85	$0.74	($0.08)	$0.50	$0.80
Weighted Average Diluted Shares Outstanding	22.79M	37.38M	56.03M	72.65M	79.39M	93.10M	95.21M	96.09M	96.70M	106.15M	155.17M
Weighted Average Basic & Diluted Shares Outstanding	31.57M	48.15M	66.22M	76.14M	88.85M	95.47M	95.89M	97.05M	99.51M	130.50M	187.66M
Cash Dividends to Common per Share	$0.13	$0.64	$0.68	$0.74	$0.82	$0.90	$1.00	$1.06	$1.10	$1.12	$1.16

This table shows CareTrust REIT's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	0.71	14	19	-0.48	8.70	26	29	11	33	52	66
Consolidated Net Income / (Loss)	0.71	14	19	-0.48	8.69	26	29	10	33	52	65
Net Income / (Loss) Continuing Operations	0.71	14	19	-0.48	8.69	26	29	10	33	52	66
Total Pre-Tax Income	0.71	14	19	-0.48	8.69	26	29	10	33	52	66
Total Operating Income	16	19	30	11	26	14	28	21	43	-20	45
Total Gross Profit	46	42	50	51	55	40	53	69	74	19	74
Total Revenue	50	43	51	52	56	41	54	69	77	20	74
Operating Revenue	50	43	51	52	56	41	54	69	77	20	74
Total Cost of Revenue	3.81	0.70	0.96	0.66	1.24	0.56	0.66	0.26	3.48	1.32	0.11
Operating Cost of Revenue	3.81	0.70	0.96	0.66	1.24	0.56	0.66	0.26	3.48	1.32	0.11
Total Operating Expenses	30	23	20	40	29	26	25	48	31	38	29
Selling, General & Admin Expense	5.16	4.81	5.06	4.72	5.52	6.51	6.84	6.14	6.66	9.29	9.02
Depreciation Expense	12	12	12	13	13	13	13	14	14	16	18
Other Operating Expenses / (Income)	0.69	0.97	0.88	1.39	2.17	1.73	1.80	1.98	2.12	8.17	2.07
Impairment Charge	12	5.36	1.89	21	8.23	4.79	2.74	26	8.42	5.35	0.00
Total Other Income / (Expense), net	-15	-5.05	-10	-11	-17	13	0.74	-11	-9.42	72	21
Interest Expense	8.36	9.61	9.83	11	12	8.27	8.23	8.68	8.94	5.12	6.67
Interest & Investment Income	-	-	-	-	-	-	9.57	-	-	-	22
Other Income / (Expense), net	-6.99	-4.06	-0.52	-0.12	-5.25	1.63	-0.60	-1.86	-0.49	9.78	5.16
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-	0.00	0.00	-0.01	-0.00	0.00	-0.34	-0.17	-0.18	-0.61
Basic Earnings per Share	$0.01	$0.15	$0.19	($0.01)	$0.08	$0.24	$0.22	$0.07	$0.21	$0.31	$0.35
Weighted Average Basic Shares Outstanding	96.61M	96.70M	99.06M	99.12M	104.01M	105.96M	132.84M	144.90M	159.46M	154.80M	187.15M
Diluted Earnings per Share	$0.01	$0.15	$0.19	($0.01)	$0.08	$0.24	$0.22	$0.07	$0.21	$0.30	$0.35
Weighted Average Diluted Shares Outstanding	96.63M	96.70M	99.09M	99.12M	104.31M	106.15M	133.20M	145.26M	159.85M	155.17M	187.42M
Weighted Average Basic & Diluted Shares Outstanding	97.03M	99.51M	99.48M	99.48M	119.11M	130.50M	142.06M	154.21M	171.45M	187.66M	191.69M
Cash Dividends to Common per Share	$0.28	-	$0.28	$0.28	$0.28	-	$0.29	$0.29	$0.29	-	$0.34

This table details how cash moves in and out of CareTrust REIT's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	24	-14	-3.97	-0.59	30	-16	-1.41	0.98	-6.72	281	-81
Net Cash From Operating Activities	22	40	64	89	99	126	146	157	144	155	244
Net Cash From Continuing Operating Activities	22	40	64	89	99	126	146	157	144	155	244
Net Income / (Loss) Continuing Operations	-8.14	10	29	26	58	46	81	72	-7.51	54	124
Consolidated Net Income / (Loss)	-8.14	10	29	26	58	46	81	72	-7.51	54	124
Depreciation Expense	23	24	32	39	46	52	53	55	50	51	57
Amortization Expense	1.60	2.20	2.24	2.10	1.94	2.00	1.95	2.05	2.10	2.05	-0.05
Non-Cash Adjustments To Reconcile Net Income	3.78	1.79	1.25	26	-0.77	30	5.10	22	100	45	43
Changes in Operating Assets and Liabilities, net	1.67	2.10	-0.39	-4.42	-5.51	-4.08	5.00	5.89	-0.32	2.39	20
Net Cash From Investing Activities	-54	-235	-285	-303	-115	-316	-42	-193	-127	-268	-1,514
Net Cash From Continuing Investing Activities	-54	-235	-285	-303	-115	-316	-42	-193	-127	-268	-1,514
Purchase of Property, Plant & Equipment	-45	-233	-281	-0.40	-9.01	-6.29	-8.30	-6.01	-7.29	-11	-8.05
Acquisitions	-8.00	-1.75	-5.36	-297	-117	-321	-3.00	0.00	0.00	-239	-57
Purchase of Investments	-	0.00	0.00	-	-	-	-30	-1.25	-150	-60	-655
Sale of Property, Plant & Equipment	-	-	2.86	0.00	13	3.50	6.61	6.96	45	16	14
Other Investing Activities, net	-0.58	-0.19	-0.76	-13	-2.42	6.04	-8.72	-192	-16	27	-807
Net Cash From Financing Activities	56	181	216	213	46	173	-106	37	-24	394	1,189
Net Cash From Continuing Financing Activities	56	181	216	213	46	173	-106	37	-24	394	1,189
Repayment of Debt	-236	-40	-301	-442	-135	-383	-75	-504	-120	-310	-284
Payment of Dividends	-33	-22	-37	-53	-63	-81	-93	-101	-106	-116	-172
Issuance of Debt	321	80	355	538	65	443	65	620	160	185	75
Issuance of Common Equity	0.00	163	200	170	180	196	-0.40	23	47	636	1,573
Other Financing Activities, net	4.36	-0.15	-0.52	-0.87	-1.29	-2.52	-2.00	-1.33	-4.47	-1.48	-2.48
Cash Interest Paid	17	22	21	30	26	26	22	23	26	40	28

This table details how cash moves in and out of CareTrust REIT's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	-25	8.32	15	-27	2.34	291	157	44	-118	-163	419
Net Cash From Operating Activities	42	34	35	32	45	43	49	53	67	75	71
Net Cash From Continuing Operating Activities	42	34	35	32	45	43	49	53	67	75	71
Net Income / (Loss) Continuing Operations	0.71	14	19	-0.48	8.69	26	29	10	33	52	65
Consolidated Net Income / (Loss)	0.71	14	19	-0.48	8.69	26	29	10	33	52	65
Depreciation Expense	12	12	12	13	13	13	13	14	14	16	18
Amortization Expense	0.52	0.54	0.61	0.61	0.61	0.23	0.04	1.19	-1.34	0.06	0.04
Non-Cash Adjustments To Reconcile Net Income	20	11	3.50	22	15	4.66	5.05	26	9.20	2.76	-3.15
Changes in Operating Assets and Liabilities, net	9.23	-4.33	-0.47	-3.47	8.07	-1.74	1.52	1.05	12	4.87	-8.56
Net Cash From Investing Activities	-16	14	-0.82	-176	-56	-36	-123	-345	-359	-686	-36
Net Cash From Continuing Investing Activities	-16	14	-0.82	-176	-56	-36	-123	-345	-359	-686	-36
Purchase of Property, Plant & Equipment	-1.85	-1.82	-2.02	-4.36	-2.76	-1.84	-0.40	-0.93	-2.87	-3.86	-2.28
Acquisitions	-22	22	-17	17	-202	-37	-4.11	-219	166	-0.39	-36
Purchase of Investments	-48	-	0.00	-27	-23	-9.63	-52	-193	-260	-150	-6.39
Sale of Property, Plant & Equipment	33	11	3.23	11	-	1.85	0.05	0.09	4.94	8.86	44
Other Investing Activities, net	22	-17	15	-172	173	11	-67	67	-267	-540	-36
Net Cash From Financing Activities	-52	-40	-19	117	13	284	231	336	174	447	383
Net Cash From Continuing Financing Activities	-52	-40	-19	117	13	284	231	336	174	447	383
Repayment of Debt	-45	-75	-0.02	-	-310	-0.05	-0.02	-	-275	-8.79	-0.14
Payment of Dividends	-27	-27	-27	-28	-28	-32	-37	-41	-45	-50	-55
Issuance of Debt	20	15	10	145	30	-	0.00	75	-	-	425
Issuance of Common Equity	-	47	-0.50	-0.13	321	316	270	303	494	506	17
Other Financing Activities, net	-	-	-1.48	-	-	-	-2.48	-	-	-0.00	-3.33
Cash Interest Paid	3.91	11	6.67	14	7.54	11	3.77	12	4.63	8.01	0.45

This table presents CareTrust REIT's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	475	673	925	1,185	1,292	1,519	1,504	1,641	1,621	2,085	3,437
Total Current Assets	28	16	15	13	57	34	31	30	25	318	347
Cash & Equivalents	25	11	7.50	6.91	37	20	19	20	13	294	214
Note & Lease Receivable	-	-	-	-	-	-	-	-	-	0.00	96
Accounts Receivable	2.29	2.34	5.90	5.25	11	2.57	1.82	2.42	0.42	0.40	1.17
Prepaid Expenses	0.81	2.08	1.37	0.90	8.67	11	10	7.51	12	23	36
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1,421	1,567	2,227
Total Noncurrent Assets	447	657	911	1,172	1,235	1,485	1,472	1,611	174	200	864
Long-Term Investments	7.53	8.48	14	18	18	33	15	15	156	180	795
Other Noncurrent Operating Assets	439	649	897	1,154	1,217	1,452	1,457	1,596	18	19	68
Total Liabilities & Shareholders' Equity	475	673	925	1,185	1,292	1,519	1,504	1,641	1,621	2,085	3,437
Total Liabilities	362	411	473	590	524	591	589	725	771	666	508
Total Current Liabilities	11	17	23	31	34	15	20	25	52	71	111
Accounts Payable	6.96	9.27	12	17	16	15	20	25	24	34	56
Dividends Payable	3.95	7.70	11	14	18	-	-	-	28	37	54
Total Noncurrent Liabilities	351	394	450	559	490	576	570	700	719	596	397
Long-Term Debt	351	394	450	559	490	555	546	673	719	596	397
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	-	-	0.00	18
Total Equity & Noncontrolling Interests	113	262	452	595	768	928	914	916	849	1,419	2,911
Total Preferred & Common Equity	113	262	452	595	768	928	914	916	849	1,417	2,908
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	113	262	452	595	768	928	914	916	849	1,417	2,908
Common Stock	246	411	612	784	966	1,164	1,165	1,198	1,246	1,884	3,441
Other Equity Adjustments	-133	-148	-160	-189	-198	-236	-251	-282	-397	-468	-533
Noncontrolling Interest	-	-	-	-	-	-	-	-	0.00	1.90	2.72

This table presents CareTrust REIT's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	1,686	1,646	1,622	1,737	1,768	2,348	2,699	2,921	3,884
Total Current Assets	38	25	58	16	25	479	527	412	199
Cash & Equivalents	30	4.86	28	1.15	3.49	451	495	377	27
Note & Lease Receivable	-	-	-	-	-	-	-	-	97
Accounts Receivable	0.88	0.81	0.44	0.39	0.38	0.40	1.10	0.88	1.95
Prepaid Expenses	6.84	19	30	14	21	28	31	34	74
Plant, Property, & Equipment, net	1,390	1,384	0.00	1,528	1,536	1,619	1,706	1,749	2,252
Total Noncurrent Assets	258	237	1,564	193	207	250	466	760	1,433
Long-Term Investments	115	159	141	167	181	233	434	741	800
Other Noncurrent Operating Assets	142	78	1,423	26	26	16	32	19	633
Total Liabilities & Shareholders' Equity	1,686	1,646	1,622	1,737	1,768	2,348	2,699	2,921	3,884
Total Liabilities	848	832	782	924	657	672	753	496	936
Total Current Liabilities	49	58	24	329	61	76	82	99	114
Accounts Payable	22	31	24	21	29	35	37	50	51
Dividends Payable	27	27	-	28	32	41	45	50	63
Total Noncurrent Liabilities	799	774	758	595	595	596	671	397	822
Long-Term Debt	799	774	730	595	595	596	671	397	822
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	-	17
Total Equity & Noncontrolling Interests	838	814	840	813	1,111	1,676	1,946	2,425	2,931
Total Preferred & Common Equity	838	814	840	813	1,110	1,674	1,944	2,422	2,927
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	837	813	840	813	1,110	1,674	1,944	2,422	2,927
Common Stock	1,195	1,197	1,246	1,247	1,567	2,154	2,458	2,953	3,457
Other Equity Adjustments	-358	-384	-405	-434	-457	-480	-514	-530	-530
Noncontrolling Interest	-	-	-	-	1.06	2.30	2.08	2.54	3.47

This table displays calculated financial ratios and metrics derived from CareTrust REIT's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	20.70%	25.62%	41.48%	27.04%	18.02%	4.12%	9.14%	7.86%	-2.52%	5.92%	15.44%
EBITDA Growth	-31.32%	261.18%	45.41%	1.58%	52.04%	-3.86%	24.11%	2.91%	-59.53%	94.04%	12.81%
EBIT Growth	-2,893.75%	506.69%	57.70%	-10.90%	84.35%	-13.17%	40.34%	1.87%	-86.97%	443.63%	17.12%
NOPAT Growth	-2,893.75%	680.99%	58.50%	-11.35%	79.95%	-13.17%	43.82%	1.91%	-83.74%	360.09%	2.27%
Net Income Growth	-1,961.52%	223.22%	192.54%	-11.85%	123.87%	-19.96%	74.44%	-10.99%	-110.43%	815.72%	131.56%
EPS Growth	-1,700.00%	172.22%	100.00%	-32.69%	105.71%	-31.94%	73.47%	-12.94%	-110.81%	725.00%	60.00%
Operating Cash Flow Growth	-17.75%	83.76%	60.06%	37.82%	11.89%	27.11%	15.39%	7.64%	-7.94%	7.17%	57.82%
Free Cash Flow Firm Growth	95.27%	-780.70%	-11.34%	-4.57%	102.69%	-2,558.06%	179.55%	-120.24%	765.38%	-148.05%	-928.21%
Invested Capital Growth	3.38%	47.92%	38.50%	28.13%	6.85%	17.01%	-0.19%	9.00%	-8.19%	10.45%	50.48%
Revenue Q/Q Growth	0.00%	8.17%	7.07%	6.55%	37.23%	-17.68%	-0.05%	3.28%	-3.63%	-5.36%	-14.79%
EBITDA Q/Q Growth	0.00%	96.38%	-6.66%	-10.23%	66.77%	-19.99%	-0.46%	-0.83%	-14.45%	-5.59%	-22.57%
EBIT Q/Q Growth	0.00%	490.43%	-12.81%	-21.05%	161.01%	-31.09%	-0.90%	-2.01%	-39.59%	-10.23%	-33.50%
NOPAT Q/Q Growth	0.00%	490.43%	-12.37%	-21.05%	171.72%	-32.60%	0.57%	-2.09%	-16.57%	-15.21%	-39.24%
Net Income Q/Q Growth	0.00%	77.19%	13.04%	-19.17%	29.77%	12.42%	0.49%	-3.74%	-107.06%	28.50%	25.99%
EPS Q/Q Growth	0.00%	36.84%	8.33%	-27.08%	28.57%	6.52%	1.19%	-3.90%	-100.00%	21.95%	8.11%
Operating Cash Flow Q/Q Growth	-0.78%	19.84%	6.09%	8.49%	5.41%	3.41%	4.45%	0.74%	-3.19%	6.12%	15.37%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-112.25%	9.15%	107.98%	-5.84%	-20.52%	61.73%	13.42%	-684.70%	-996.65%
Invested Capital Q/Q Growth	0.00%	-1.33%	10.84%	4.98%	2.77%	0.37%	2.41%	-0.24%	-1.68%	1.41%	35.27%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	97.56%	97.94%	98.11%	98.23%	98.95%	100.00%	97.31%	98.28%	97.51%
EBITDA Margin	27.95%	80.35%	82.58%	66.03%	85.07%	78.55%	89.33%	85.23%	35.39%	64.83%	63.35%
Operating Margin	-13.83%	44.76%	50.14%	34.99%	53.35%	44.50%	58.64%	55.40%	13.20%	40.13%	35.55%
EBIT Margin	-13.83%	44.76%	49.89%	34.99%	54.66%	45.58%	58.61%	55.36%	7.40%	37.98%	38.54%
Profit (Net Income) Margin	-13.83%	13.56%	28.04%	19.46%	36.91%	28.37%	45.35%	37.42%	-4.00%	27.05%	54.26%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	100.00%	30.30%	56.20%	55.60%	67.52%	62.24%	77.36%	67.60%	-54.09%	71.22%	140.80%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.33%	6.14%	6.84%	4.57%	7.08%	5.49%	7.33%	7.15%	1.16%	5.31%	4.13%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.17%	-0.43%	1.20%	0.39%	1.93%	-0.04%	2.65%	1.14%	-2.92%	-1.76%	-17.29%
Return on Net Nonoperating Assets (RNNOA)	-4.57%	-0.80%	1.38%	0.37%	1.42%	-0.02%	1.46%	0.72%	-2.01%	-0.57%	1.59%
Return on Equity (ROE)	-5.90%	5.34%	8.21%	4.94%	8.50%	5.47%	8.78%	7.87%	-0.85%	4.74%	5.72%
Cash Return on Invested Capital (CROIC)	-4.65%	-32.52%	-25.45%	-20.09%	0.46%	-10.18%	7.52%	-1.46%	9.70%	-4.63%	-36.18%
Operating Return on Assets (OROA)	-1.80%	5.77%	6.53%	4.41%	6.93%	5.30%	6.92%	6.77%	0.85%	4.07%	3.20%
Return on Assets (ROA)	-1.80%	1.75%	3.67%	2.45%	4.68%	3.30%	5.35%	4.58%	-0.46%	2.90%	4.51%
Return on Common Equity (ROCE)	-5.90%	5.34%	8.21%	4.94%	8.50%	5.47%	8.78%	7.87%	-0.85%	4.73%	5.69%
Return on Equity Simple (ROE_SIMPLE)	-7.18%	3.83%	6.49%	4.35%	7.54%	5.00%	8.85%	7.86%	-0.88%	3.79%	4.28%
Net Operating Profit after Tax (NOPAT)	-5.70	33	52	47	84	73	105	107	17	80	82
NOPAT Margin	-9.68%	44.76%	50.14%	34.99%	53.35%	44.50%	58.64%	55.40%	9.24%	40.13%	35.55%
Net Nonoperating Expense Percent (NNEP)	0.84%	6.56%	5.64%	4.18%	5.16%	5.53%	4.68%	6.01%	4.08%	7.07%	21.42%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	1.10%	3.96%	2.46%
Cost of Revenue to Revenue	0.00%	0.00%	2.44%	2.06%	1.89%	1.77%	1.05%	0.00%	2.69%	1.72%	2.49%
SG&A Expenses to Revenue	18.86%	10.35%	8.88%	8.36%	8.00%	9.28%	9.14%	13.97%	10.75%	10.98%	12.62%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	113.83%	55.24%	47.42%	62.95%	44.76%	53.73%	40.32%	44.60%	84.11%	58.14%	61.95%
Earnings before Interest and Taxes (EBIT)	-8.14	33	52	47	86	74	105	106	14	75	88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	16	59	86	88	134	128	159	164	66	129	145
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.52	1.32	1.35	1.54	1.52	1.67	1.93	2.11	1.92	1.80	1.59
Price to Tangible Book Value (P/TBV)	1.52	1.32	1.35	1.54	1.52	1.67	1.93	2.11	1.92	1.80	1.59
Price to Revenue (P/Rev)	2.92	4.67	5.85	6.87	7.45	9.48	9.89	10.03	8.70	12.84	20.23
Price to Earnings (P/E)	0.00	34.40	20.85	35.29	20.19	33.42	21.82	26.81	0.00	47.47	37.08
Dividend Yield	78.34%	8.93%	6.45%	6.15%	5.88%	5.55%	5.43%	5.33%	6.54%	5.23%	4.29%
Earnings Yield	0.00%	2.91%	4.80%	2.83%	4.95%	2.99%	4.58%	3.73%	0.00%	2.11%	2.70%
Enterprise Value to Invested Capital (EV/IC)	1.13	1.12	1.17	1.27	1.31	1.44	1.60	1.65	1.53	1.70	1.71
Enterprise Value to Revenue (EV/Rev)	8.32	9.72	9.94	10.88	10.22	12.55	12.76	13.35	11.64	13.46	17.65
Enterprise Value to EBITDA (EV/EBITDA)	29.76	12.10	12.04	16.48	12.02	15.97	14.29	15.66	32.89	20.77	27.86
Enterprise Value to EBIT (EV/EBIT)	0.00	21.72	19.92	31.10	18.70	27.52	21.77	24.12	157.26	35.44	45.80
Enterprise Value to NOPAT (EV/NOPAT)	0.00	21.72	19.82	31.10	19.16	28.20	21.77	24.10	125.97	33.54	49.64
Enterprise Value to Operating Cash Flow (EV/OCF)	22.36	17.87	16.15	16.30	16.15	16.23	15.62	16.37	15.11	17.27	16.57
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	292.25	0.00	21.20	0.00	15.10	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	3.09	1.50	0.99	0.94	0.64	0.60	0.60	0.74	0.85	0.42	0.14
Long-Term Debt to Equity	3.09	1.50	0.99	0.94	0.64	0.60	0.60	0.74	0.85	0.42	0.14
Financial Leverage	2.10	1.87	1.15	0.94	0.73	0.56	0.55	0.63	0.69	0.32	-0.09
Leverage Ratio	3.28	3.06	2.24	2.02	1.82	1.66	1.64	1.72	1.85	1.63	1.27
Compound Leverage Factor	3.28	0.93	1.26	1.12	1.23	1.03	1.27	1.16	-1.00	1.16	1.79
Debt to Total Capital	75.56%	60.03%	49.85%	48.45%	38.93%	37.42%	37.38%	42.37%	45.86%	29.57%	11.93%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	75.56%	60.03%	49.85%	48.45%	38.93%	37.42%	37.38%	42.37%	45.86%	29.57%	11.93%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.09%	0.63%
Common Equity to Total Capital	24.44%	39.97%	50.15%	51.55%	61.07%	62.58%	62.62%	57.63%	54.14%	70.34%	87.44%
Debt to EBITDA	21.31	6.63	5.20	6.37	3.67	4.32	3.43	4.11	10.84	4.63	2.73
Net Debt to EBITDA	19.31	6.29	4.96	6.08	3.26	3.90	3.21	3.89	8.29	0.94	-4.21
Long-Term Debt to EBITDA	21.31	6.63	5.20	6.37	3.67	4.32	3.43	4.11	10.84	4.63	2.73
Debt to NOPAT	-61.54	11.89	8.57	12.01	5.85	7.63	5.22	6.32	41.53	7.47	4.87
Net Debt to NOPAT	-55.77	11.29	8.16	11.48	5.19	6.89	4.89	5.99	31.75	1.52	-7.51
Long-Term Debt to NOPAT	-61.54	11.89	8.57	12.01	5.85	7.63	5.22	6.32	41.53	7.47	4.87
Altman Z-Score	0.40	0.77	1.06	1.15	1.70	1.86	2.15	1.93	1.39	2.65	5.72
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.08%	0.53%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.61	0.94	0.64	0.42	1.68	2.26	1.59	1.17	0.49	4.51	3.13
Quick Ratio	2.53	0.81	0.58	0.39	1.43	1.53	1.06	0.88	0.26	4.18	2.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	-176	-195	-204	5.49	-135	107	-22	145	-69	-714
Operating Cash Flow to CapEx	48.66%	17.30%	23.13%	22,034.74%	0.00%	4,526.70%	8,628.48%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	-7.30	-8.54	-8.44	0.20	-4.80	4.54	-0.63	4.82	-1.70	-23.06
Operating Cash Flow to Interest Expense	0.00	1.67	2.82	3.67	3.57	4.49	6.16	4.55	4.81	3.79	7.89
Operating Cash Flow Less CapEx to Interest Expense	0.00	-8.00	-9.36	3.65	3.71	4.39	6.09	4.57	6.07	3.92	8.08
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.13	0.13	0.13	0.13	0.13	0.12	0.12	0.12	0.12	0.11	0.08
Accounts Receivable Turnover	0.00	31.94	25.41	23.85	18.86	23.41	81.17	90.71	132.33	489.76	292.25
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.13	0.12
Accounts Payable Turnover	0.00	0.00	0.24	0.19	0.18	0.19	0.11	0.00	0.20	0.12	0.13
Days Sales Outstanding (DSO)	0.00	11.43	14.36	15.30	19.35	15.59	4.50	4.02	2.76	0.75	1.25
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	1,532.60	1,973.24	2,055.28	1,947.74	3,372.10	0.00	1,802.47	3,111.08	2,884.42
Cash Conversion Cycle (CCC)	0.00	11.43	-1,518.24	-1,957.94	-2,035.93	-1,932.15	-3,367.60	4.02	-1,799.71	-3,110.34	-2,883.17
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	435	644	892	1,143	1,221	1,429	1,426	1,554	1,427	1,576	2,372
Invested Capital Turnover	0.14	0.14	0.14	0.13	0.13	0.12	0.13	0.13	0.13	0.13	0.12
Increase / (Decrease) in Invested Capital	14	209	248	251	78	208	-2.77	128	-127	149	796
Enterprise Value (EV)	490	719	1,040	1,447	1,604	2,050	2,276	2,568	2,182	2,674	4,047
Market Capitalization	172	345	612	913	1,169	1,549	1,764	1,930	1,632	2,551	4,638
Book Value per Share	$5.06	$5.45	$7.79	$7.83	$9.16	$9.71	$9.55	$9.44	$8.75	$11.89	$16.96
Tangible Book Value per Share	$5.06	$5.45	$7.79	$7.83	$9.16	$9.71	$9.55	$9.44	$8.75	$11.89	$16.96
Total Capital	464	656	902	1,154	1,258	1,482	1,460	1,589	1,569	2,014	3,326
Total Debt	351	394	450	559	490	555	546	673	719	596	397
Total Long-Term Debt	351	394	450	559	490	555	546	673	719	596	397
Net Debt	318	374	428	534	435	501	512	638	550	121	-612
Capital Expenditures (CapEx)	45	233	279	0.40	-3.99	2.79	1.69	-0.95	-38	-5.34	-5.89
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-7.81	-13	-16	-25	-14	-1.54	-7.30	-15	-40	-47	22
Debt-free Net Working Capital (DFNWC)	18	-1.08	-8.45	-18	23	19	12	4.42	-27	248	236
Net Working Capital (NWC)	18	-1.08	-8.45	-18	23	19	12	4.42	-27	248	236
Net Nonoperating Expense (NNE)	2.44	23	23	21	26	26	24	35	25	26	-43
Net Nonoperating Obligations (NNO)	322	382	439	548	453	501	512	638	578	157	-558
Total Depreciation and Amortization (D&A)	25	26	34	41	48	54	55	57	52	53	57
Debt-free, Cash-free Net Working Capital to Revenue	-13.25%	-16.96%	-15.23%	-19.03%	-8.73%	-0.94%	-4.09%	-8.05%	-21.23%	-23.56%	9.63%
Debt-free Net Working Capital to Revenue	29.74%	-1.46%	-8.07%	-13.84%	14.72%	11.50%	6.52%	2.30%	-14.20%	124.70%	102.89%
Net Working Capital to Revenue	29.74%	-1.46%	-8.07%	-13.84%	14.72%	11.50%	6.52%	2.30%	-14.20%	124.70%	102.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.36)	$0.26	$0.52	$0.35	$0.73	$0.49	$0.85	$0.74	($0.08)	$0.50	$0.81
Adjusted Weighted Average Basic Shares Outstanding	22.79M	37.38M	56.03M	72.65M	79.39M	93.09M	95.20M	96.02M	96.70M	105.96M	154.80M
Adjusted Diluted Earnings per Share	($0.36)	$0.26	$0.52	$0.35	$0.72	$0.49	$0.85	$0.74	($0.08)	$0.50	$0.80
Adjusted Weighted Average Diluted Shares Outstanding	22.79M	37.38M	56.03M	72.65M	79.39M	93.10M	95.21M	96.09M	96.70M	106.15M	155.17M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.57M	48.15M	66.22M	76.14M	88.85M	95.47M	95.89M	97.05M	99.51M	130.50M	187.66M
Normalized Net Operating Profit after Tax (NOPAT)	-5.67	23	37	33	59	63	73	75	73	81	87
Normalized NOPAT Margin	-9.62%	31.33%	35.24%	24.96%	37.35%	38.30%	41.04%	38.78%	38.75%	40.89%	37.78%
Pre Tax Income Margin	-13.83%	13.56%	28.04%	19.46%	36.91%	28.37%	45.35%	37.42%	-4.00%	27.05%	54.26%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	1.38	2.28	1.92	3.08	2.65	4.42	3.09	0.46	1.85	2.85
NOPAT to Interest Expense	0.00	1.38	2.29	1.92	3.01	2.59	4.42	3.09	0.58	1.95	2.63
EBIT Less CapEx to Interest Expense	0.00	-8.30	-9.89	1.91	3.22	2.55	4.35	3.11	1.72	1.98	3.04
NOPAT Less CapEx to Interest Expense	0.00	-8.30	-9.88	1.91	3.15	2.49	4.35	3.12	1.84	2.08	2.82
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-405.27%	217.16%	126.97%	203.24%	108.76%	173.90%	115.20%	140.01%	-1,414.04%	215.06%	138.45%
Augmented Payout Ratio	-405.27%	217.16%	126.97%	203.24%	108.76%	173.90%	115.20%	140.01%	-1,414.04%	215.06%	138.45%

This table displays calculated financial ratios and metrics derived from CareTrust REIT's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.47%	-14.05%	8.89%	8.41%	11.10%	-6.07%	5.72%	33.63%	38.48%	-50.87%	39.16%
EBITDA Growth	-49.10%	-28.70%	279.06%	-40.36%	56.00%	3.60%	-2.40%	42.98%	61.06%	-80.30%	67.40%
EBIT Growth	-68.13%	-37.18%	177.43%	-60.86%	125.45%	0.18%	-5.66%	80.91%	106.58%	-164.59%	84.54%
NOPAT Growth	-43.53%	-20.19%	212.06%	-72.29%	59.97%	-29.18%	-5.30%	180.30%	66.24%	-243.33%	62.15%
Net Income Growth	-94.05%	-21.25%	144.44%	-102.34%	1,124.96%	82.85%	49.53%	2,252.48%	283.14%	97.59%	126.76%
EPS Growth	-91.67%	-21.05%	142.22%	-104.76%	700.00%	60.00%	15.79%	800.00%	162.50%	25.00%	59.09%
Operating Cash Flow Growth	-11.37%	-12.37%	1.56%	-5.51%	6.47%	26.46%	39.01%	66.24%	49.08%	76.25%	46.21%
Free Cash Flow Firm Growth	189.48%	241.09%	1,811.53%	-106.06%	-162.86%	-192.32%	-227.20%	-649.80%	-102.93%	-502.20%	-568.60%
Invested Capital Growth	-6.85%	-8.19%	-8.32%	1.93%	7.09%	10.45%	16.23%	11.95%	12.82%	50.48%	84.64%
Revenue Q/Q Growth	5.76%	-14.14%	-2.32%	1.87%	8.39%	-27.41%	31.90%	9.23%	12.32%	-74.25%	273.61%
EBITDA Q/Q Growth	-45.45%	27.38%	14.95%	-42.99%	42.67%	-15.40%	41.85%	-32.32%	60.72%	-89.65%	1,105.28%
EBIT Q/Q Growth	-66.39%	69.48%	21.12%	-63.67%	93.59%	-24.69%	78.11%	-48.36%	121.05%	-123.54%	608.92%
NOPAT Q/Q Growth	-40.47%	20.98%	5.44%	-74.73%	243.61%	-46.44%	103.60%	-44.24%	103.79%	-146.18%	330.33%
Net Income Q/Q Growth	-96.57%	1,928.21%	33.71%	-102.52%	1,894.42%	202.75%	9.34%	-63.76%	219.41%	56.13%	25.48%
EPS Q/Q Growth	-95.24%	1,400.00%	26.67%	-105.26%	900.00%	200.00%	-8.33%	-68.18%	200.00%	42.86%	16.67%
Operating Cash Flow Q/Q Growth	25.64%	-20.36%	4.08%	-9.27%	41.56%	-5.41%	14.41%	8.51%	26.94%	11.84%	-5.09%
Free Cash Flow Firm Q/Q Growth	-66.00%	19.48%	0.94%	-113.96%	-252.61%	-75.48%	-47.25%	13.56%	4.57%	-420.73%	-63.49%
Invested Capital Q/Q Growth	-4.44%	-1.68%	-1.80%	10.47%	0.39%	1.41%	3.34%	6.41%	1.17%	35.27%	26.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	92.43%	98.39%	98.10%	98.72%	97.78%	98.61%	98.77%	99.63%	95.51%	93.37%	99.86%
EBITDA Margin	43.45%	64.46%	82.83%	46.35%	61.01%	71.10%	76.47%	49.59%	70.96%	28.51%	91.98%
Operating Margin	31.93%	44.98%	58.45%	20.71%	45.97%	33.92%	52.36%	30.41%	55.18%	-98.95%	61.00%
EBIT Margin	18.02%	35.57%	57.41%	20.48%	36.57%	37.94%	51.23%	27.72%	54.55%	-49.87%	67.94%
Profit (Net Income) Margin	1.41%	33.30%	37.99%	-0.94%	15.54%	64.82%	53.74%	15.12%	43.00%	260.71%	87.56%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	98.66%
Interest Burden Percent	7.82%	93.61%	66.18%	-4.59%	42.50%	170.86%	104.89%	54.55%	78.83%	-522.74%	130.64%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	4.13%	5.66%	7.99%	1.93%	6.42%	4.49%	6.96%	4.59%	8.98%	-11.49%	6.59%
ROIC Less NNEP Spread (ROIC-NNEP)	1.73%	4.83%	6.33%	0.81%	3.27%	7.90%	7.25%	0.55%	17.23%	-47.30%	352.32%
Return on Net Nonoperating Assets (RNNOA)	1.27%	3.33%	4.67%	0.69%	1.84%	2.56%	1.48%	0.11%	-1.11%	4.36%	0.87%
Return on Equity (ROE)	5.40%	8.99%	12.67%	2.62%	8.26%	7.05%	8.44%	4.70%	7.87%	-7.14%	7.46%
Cash Return on Invested Capital (CROIC)	8.47%	9.70%	15.55%	3.59%	-0.59%	-4.63%	-9.85%	-4.14%	-3.94%	-36.18%	-55.20%
Operating Return on Assets (OROA)	2.13%	4.09%	7.15%	2.44%	4.50%	4.07%	5.20%	3.09%	6.26%	-4.14%	5.45%
Return on Assets (ROA)	0.17%	3.83%	4.73%	-0.11%	1.91%	6.95%	5.45%	1.69%	4.94%	21.65%	7.03%
Return on Common Equity (ROCE)	5.40%	8.99%	12.66%	2.62%	8.25%	7.04%	8.44%	4.69%	7.86%	-7.10%	7.42%
Return on Equity Simple (ROE_SIMPLE)	-0.45%	0.00%	6.54%	4.16%	3.77%	0.00%	3.78%	3.81%	4.08%	0.00%	5.49%
Net Operating Profit after Tax (NOPAT)	16	19	30	7.48	26	14	28	21	43	-20	45
NOPAT Margin	31.93%	44.98%	58.45%	14.50%	45.97%	33.92%	52.36%	30.41%	55.18%	-98.95%	61.00%
Net Nonoperating Expense Percent (NNEP)	2.40%	0.83%	1.66%	1.12%	3.15%	-3.41%	-0.29%	4.04%	-8.25%	35.80%	-345.73%
Return On Investment Capital (ROIC_SIMPLE)	-	1.24%	-	-	-	0.68%	1.23%	-	-	-0.60%	1.21%
Cost of Revenue to Revenue	7.57%	1.61%	1.90%	1.28%	2.22%	1.39%	1.23%	0.37%	4.49%	6.63%	0.14%
SG&A Expenses to Revenue	10.26%	11.15%	10.00%	9.15%	9.88%	16.04%	12.78%	8.91%	8.61%	46.60%	12.12%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	60.50%	53.41%	39.65%	78.01%	51.81%	64.69%	46.41%	69.22%	40.33%	192.32%	38.86%
Earnings before Interest and Taxes (EBIT)	9.06	15	29	11	20	15	27	19	42	-9.94	51
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	22	28	42	24	34	29	41	34	55	5.68	68
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.97	1.92	2.17	2.31	1.76	1.80	1.66	1.83	1.96	1.59	1.83
Price to Tangible Book Value (P/TBV)	1.97	1.92	2.17	2.31	1.76	1.80	1.66	1.83	1.96	1.59	1.83
Price to Revenue (P/Rev)	8.22	8.70	9.12	9.20	9.29	12.84	13.79	14.40	17.69	20.23	21.43
Price to Earnings (P/E)	0.00	0.00	33.23	55.54	46.59	47.47	43.93	47.87	47.95	37.08	33.08
Dividend Yield	6.61%	6.54%	6.02%	5.88%	5.69%	5.23%	4.84%	4.54%	3.73%	4.29%	4.22%
Earnings Yield	0.00%	0.00%	3.01%	1.80%	2.15%	2.11%	2.28%	2.09%	2.09%	2.70%	3.02%
Enterprise Value to Invested Capital (EV/IC)	1.52	1.53	1.70	1.67	1.52	1.70	1.65	1.91	2.30	1.71	1.79
Enterprise Value to Revenue (EV/Rev)	11.36	11.64	11.92	12.66	11.25	13.46	13.36	13.37	15.02	17.65	21.50
Enterprise Value to EBITDA (EV/EBITDA)	28.50	32.89	17.02	20.84	17.31	20.77	21.08	19.85	21.54	27.86	31.13
Enterprise Value to EBIT (EV/EBIT)	96.23	157.26	26.81	35.59	28.09	35.44	36.49	29.80	30.41	45.80	48.24
Enterprise Value to NOPAT (EV/NOPAT)	106.46	125.97	23.72	30.66	25.11	33.54	34.46	28.26	30.12	49.64	54.39
Enterprise Value to Operating Cash Flow (EV/OCF)	14.82	15.11	16.47	18.07	16.18	17.27	15.98	17.46	19.08	16.57	20.16
Enterprise Value to Free Cash Flow (EV/FCFF)	17.34	15.10	10.48	47.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.95	0.85	0.87	1.08	0.54	0.42	0.36	0.34	0.16	0.14	0.28
Long-Term Debt to Equity	0.95	0.85	0.87	0.73	0.54	0.42	0.36	0.34	0.16	0.14	0.28
Financial Leverage	0.74	0.69	0.74	0.86	0.56	0.32	0.20	0.19	-0.06	-0.09	0.00
Leverage Ratio	1.90	1.85	1.91	2.07	1.77	1.63	1.58	1.61	1.33	1.27	1.35
Compound Leverage Factor	0.15	1.73	1.26	-0.10	0.75	2.79	1.66	0.88	1.05	-6.64	1.76
Debt to Total Capital	48.76%	45.86%	46.48%	51.84%	34.89%	29.57%	26.23%	25.65%	14.06%	11.93%	21.81%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	16.59%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	48.76%	45.86%	46.48%	35.25%	34.89%	29.57%	26.23%	25.65%	14.06%	11.93%	21.81%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.06%	0.09%	0.10%	0.08%	0.09%	0.63%	0.55%
Common Equity to Total Capital	51.18%	54.14%	53.52%	48.16%	65.05%	70.34%	73.67%	74.27%	85.85%	87.44%	77.64%
Debt to EBITDA	9.98	10.84	5.20	7.05	4.37	4.63	4.66	4.02	2.12	2.73	4.76
Net Debt to EBITDA	7.87	8.29	4.00	5.70	3.01	0.94	-0.69	-1.54	-3.84	-4.21	-0.02
Long-Term Debt to EBITDA	9.98	10.84	5.20	4.79	4.37	4.63	4.66	4.02	2.12	2.73	4.76
Debt to NOPAT	37.29	41.53	7.25	10.37	6.33	7.47	7.63	5.73	2.96	4.87	8.31
Net Debt to NOPAT	29.41	31.75	5.57	8.38	4.37	1.52	-1.13	-2.20	-5.38	-7.51	-0.04
Long-Term Debt to NOPAT	37.29	41.53	7.25	7.05	6.33	7.47	7.63	5.73	2.96	4.87	8.31
Altman Z-Score	1.27	1.40	1.61	1.14	1.91	2.56	2.81	3.15	6.02	5.62	3.57
Noncontrolling Interest Sharing Ratio	0.06%	0.00%	0.06%	0.06%	0.11%	0.08%	0.09%	0.08%	0.10%	0.53%	0.50%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.43	0.49	2.40	0.05	0.40	4.51	6.27	6.44	4.14	3.13	1.74
Quick Ratio	0.10	0.26	1.18	0.00	0.06	4.18	5.91	6.06	3.80	2.81	1.10
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	123	147	157	-22	-77	-135	-199	-164	-157	-815	-1,333
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	1,635.01%	0.00%	13,869.32%	6,374.85%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	14.69	15.26	15.95	-1.98	-6.57	-16.38	-24.23	-18.91	-17.52	-159.19	-199.88
Operating Cash Flow to Interest Expense	5.07	3.51	3.57	2.89	3.84	5.16	5.93	6.10	7.52	14.68	10.70
Operating Cash Flow Less CapEx to Interest Expense	8.82	4.47	3.70	3.51	3.60	5.16	5.89	6.01	7.75	15.66	17.02
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.12	0.12	0.12	0.12	0.12	0.11	0.10	0.11	0.11	0.08	0.08
Accounts Receivable Turnover	90.88	132.33	258.24	323.71	352.39	489.76	478.04	333.88	425.75	292.25	212.41
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.14	0.14	0.13	0.00	0.15	0.16	0.12	0.13
Accounts Payable Turnover	0.15	0.20	0.23	0.29	0.12	0.12	0.11	0.09	0.13	0.13	0.12
Days Sales Outstanding (DSO)	4.02	2.76	1.41	1.13	1.04	0.75	0.76	1.09	0.86	1.25	1.72
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	2,419.51	1,802.47	1,575.32	1,275.12	3,065.02	3,111.08	3,476.86	3,905.98	2,893.89	2,884.42	3,054.43
Cash Conversion Cycle (CCC)	-2,415.49	-1,799.71	-1,573.90	-1,273.99	-3,063.99	-3,110.34	-3,476.10	-3,904.89	-2,893.03	-2,883.17	-3,052.71
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,451	1,427	1,401	1,548	1,554	1,576	1,629	1,733	1,753	2,372	3,007
Invested Capital Turnover	0.13	0.13	0.14	0.13	0.14	0.13	0.13	0.15	0.16	0.12	0.11
Increase / (Decrease) in Invested Capital	-107	-127	-127	29	103	149	227	185	199	796	1,378
Enterprise Value (EV)	2,210	2,182	2,388	2,586	2,360	2,674	2,692	3,310	4,040	4,047	5,380
Market Capitalization	1,600	1,632	1,827	1,879	1,948	2,551	2,779	3,566	4,759	4,638	5,363
Book Value per Share	$8.38	$8.75	$8.44	$8.17	$11.16	$11.89	$12.60	$13.68	$15.71	$16.96	$15.60
Tangible Book Value per Share	$8.38	$8.75	$8.44	$8.17	$11.16	$11.89	$12.60	$13.68	$15.71	$16.96	$15.60
Total Capital	1,588	1,569	1,570	1,688	1,706	2,014	2,272	2,617	2,821	3,326	3,770
Total Debt	774	719	730	875	595	596	596	671	397	397	822
Total Long-Term Debt	774	719	730	595	595	596	596	671	397	397	822
Net Debt	611	550	561	707	411	121	-89	-258	-721	-612	-4.16
Capital Expenditures (CapEx)	-31	-9.22	-1.21	-6.87	2.76	-0.01	0.35	0.83	-2.06	-5.01	-42
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-38	-40	5.79	-34	-40	-47	-48	-50	-65	22	58
Debt-free Net Working Capital (DFNWC)	-33	-27	34	-33	-37	248	403	445	312	236	85
Net Working Capital (NWC)	-33	-27	34	-313	-37	248	403	445	312	236	85
Net Nonoperating Expense (NNE)	15	5.05	10	7.96	17	-13	-0.74	11	9.42	-72	-20
Net Nonoperating Obligations (NNO)	638	578	561	735	443	157	-47	-213	-671	-558	59
Total Depreciation and Amortization (D&A)	13	12	13	13	14	13	14	15	13	16	18
Debt-free, Cash-free Net Working Capital to Revenue	-19.44%	-21.23%	2.89%	-16.87%	-19.15%	-23.56%	-23.98%	-20.29%	-24.06%	9.63%	23.32%
Debt-free Net Working Capital to Revenue	-16.94%	-14.20%	16.91%	-16.31%	-17.49%	124.70%	199.93%	179.70%	116.09%	102.89%	33.91%
Net Working Capital to Revenue	-16.94%	-14.20%	16.91%	-153.39%	-17.49%	124.70%	199.93%	179.70%	116.09%	102.89%	33.91%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.01	$0.15	$0.19	($0.01)	$0.08	$0.24	$0.22	$0.07	$0.21	$0.31	$0.35
Adjusted Weighted Average Basic Shares Outstanding	96.61M	96.70M	99.06M	99.12M	104.01M	105.96M	132.84M	144.90M	159.46M	154.80M	187.15M
Adjusted Diluted Earnings per Share	$0.01	$0.15	$0.19	($0.01)	$0.08	$0.24	$0.22	$0.07	$0.21	$0.30	$0.35
Adjusted Weighted Average Diluted Shares Outstanding	96.63M	96.70M	99.09M	99.12M	104.31M	106.15M	133.20M	145.26M	159.85M	155.17M	187.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	97.03M	99.51M	99.48M	99.48M	119.11M	130.50M	142.06M	154.21M	171.45M	187.66M	191.69M
Normalized Net Operating Profit after Tax (NOPAT)	20	17	22	22	24	13	22	33	36	-10	32
Normalized NOPAT Margin	39.50%	40.17%	43.52%	43.55%	42.49%	32.01%	40.24%	47.42%	46.24%	-50.46%	42.70%
Pre Tax Income Margin	1.41%	33.30%	37.99%	-0.94%	15.54%	64.82%	53.74%	15.12%	43.00%	260.71%	88.76%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.08	1.60	2.96	0.96	1.74	1.86	3.33	2.20	4.72	-1.94	7.58
NOPAT to Interest Expense	1.92	2.02	3.01	0.68	2.19	1.66	3.40	2.41	4.78	-3.85	6.81
EBIT Less CapEx to Interest Expense	4.83	2.56	3.08	1.58	1.50	1.86	3.29	2.10	4.95	-0.96	13.90
NOPAT Less CapEx to Interest Expense	5.67	2.98	3.13	1.30	1.95	1.67	3.36	2.32	5.01	-2.87	13.13
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-2,899.64%	-1,414.04%	195.51%	320.90%	262.51%	215.06%	197.17%	186.20%	156.93%	138.45%	118.72%
Augmented Payout Ratio	-2,899.64%	-1,414.04%	195.51%	320.90%	262.51%	215.06%	197.17%	186.20%	156.93%	138.45%	118.72%

Key Financial Trends

CareTrust REIT delivered a robust set of Q1 2025 results, highlighted by strong revenue and margin expansion, a conservative leverage profile and continued dividend growth. The REIT’s strategic acquisitions and disciplined capital deployment underpin its long-term growth trajectory, although free cash flow remains pressured by heavy investment activity.

Revenue Growth: Q1 2025 operating revenue rose 39% YoY to $74.5 million, with EBITDA up 68%, reflecting strong portfolio performance.
High Margins: Q1 2025 gross margin of 99.9%, EBITDA margin of 92.0% and operating margin of 61.0% underscore efficient cost management.
Net Debt Neutrality: Net debt swung slightly negative (–$4.2 million) in Q1 2025 after $425 million of debt issuance and equity raises, providing financial flexibility.
Dividend Growth: Cash dividends to common rose to $0.335/share in Q1 2025, equating to a ~4.2% yield and demonstrating a commitment to shareholder returns.
Acquisitions and CapEx: Q1 2025 acquisitions of $36.1 million and PP&E purchases of $2.3 million boosted invested capital to $3.01 billion, supporting future revenue growth.
Balance Sheet Leverage: Long-term debt to total capital stood at 21.8% in Q1 2025, a moderate level for a REIT focused on asset expansion.
Liquidity: Cash & equivalents of $26.5 million plus undrawn credit facilities enhance short-term liquidity despite high investment needs.
Free Cash Flow Pressure: Q1 2025 free cash flow to firm was deeply negative (–$1.33 billion) as capital deployment outstripped operating cash flow.
Operating Cash Flow Volatility: Q/Q operating cash flow dipped 5%, indicating some variability in core cash generation.
Working Capital Intensity: Net working capital to revenue at 34% ties up liquidity and may pressure short-term cash needs.

07/07/25 01:35 AMAI Generated. May Contain Errors.

Frequently Asked Questions About CareTrust REIT's Financials

When does CareTrust REIT's financial year end?

According to the most recent income statement we have on file, CareTrust REIT's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CareTrust REIT's net income changed over the last 10 years?

CareTrust REIT's net income appears to be on an upward trend, with a most recent value of $124.40 million in 2024, falling from -$8.14 million in 2014. The previous period was $53.72 million in 2023.

What is CareTrust REIT's operating income?

CareTrust REIT's total operating income in 2024 was $81.51 million, based on the following breakdown:

Total Gross Profit: $223.56 million
Total Operating Expenses: $142.04 million

How has CareTrust REIT's revenue changed over the last 10 years?

Over the last 10 years, CareTrust REIT's total revenue changed from $58.90 million in 2014 to $229.27 million in 2024, a change of 289.3%.

How much debt does CareTrust REIT have?

CareTrust REIT's total liabilities were at $507.63 million at the end of 2024, a 23.8% decrease from 2023, and a 40.4% increase since 2014.

How much cash does CareTrust REIT have?

In the past 10 years, CareTrust REIT's cash and equivalents has ranged from $6.91 million in 2017 to $294.45 million in 2023, and is currently $213.82 million as of their latest financial filing in 2024.

How has CareTrust REIT's book value per share changed over the last 10 years?

Over the last 10 years, CareTrust REIT's book value per share changed from 5.06 in 2014 to 16.96 in 2024, a change of 235.4%.

Related Companies

This page (NYSE:CTRE) was last updated on 7/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareTrust REIT (CTRE) Financials

Key Financial Trends

Frequently Asked Questions About CareTrust REIT's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CareTrust REIT (CTRE) Financials

Annual Income Statements for CareTrust REIT

Quarterly Income Statements for CareTrust REIT

Annual Cash Flow Statements for CareTrust REIT

Quarterly Cash Flow Statements for CareTrust REIT

Annual Balance Sheets for CareTrust REIT

Quarterly Balance Sheets for CareTrust REIT

Annual Metrics And Ratios for CareTrust REIT

Quarterly Metrics And Ratios for CareTrust REIT

Key Financial Trends

Frequently Asked Questions About CareTrust REIT's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools